Loading…
Based on limited metadata available, the FDA issued a Warning Letter to melanopharmacy.com on September 2, 2020, regarding drug products. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the metadata alone. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the available information. To understand the detailed violations and required corrective actions, the complete Warning Letter would need to be reviewed.